{"id":13762,"date":"2023-05-02T10:21:00","date_gmt":"2023-05-02T10:21:00","guid":{"rendered":"https:\/\/www.drfz.de\/neuigkeiten\/der-neue-vorstand-ist-komplett\/"},"modified":"2025-03-11T13:46:23","modified_gmt":"2025-03-11T13:46:23","slug":"der-neue-vorstand-ist-komplett","status":"publish","type":"post","link":"https:\/\/www.drfz.de\/en\/neuigkeiten\/der-neue-vorstand-ist-komplett\/","title":{"rendered":"The new Board of Directors is complete"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Since 1 May 2023, Prof. Dr. med. Eicke Latz is the new Scientific Director of the DRFZ and Professor for Experimental Rheumatology at the Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin. Together with Uta Bielfeldt, Administrative Director, he now heads the DRFZ.<\/p>\n\n\n\n<h2 class=\"wp-block-heading toc-item\" id=\"targeting-chronic-inflammation-prof-dr-eicke-latz-starts-at-charite-and-drfz\">Targeting chronic inflammation: Prof. Dr. Eicke Latz starts at Charit\u00e9 and DRFZ<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>New Professor of Experimental Rheumatology and Scientific Director of the DRFZ<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin appointed Prof. Dr. Eicke Latz as Professor of Experimental Rheumatology on 1 May. He simultaneously became the new Scientific Director of the German Rheumatism Research Centre Berlin (DRFZ), a Leibniz Institute. At the interface of both institutes, Prof. Latz will research chronic inflammatory and rheumatic diseases. Through new insights into molecular inflammatory mechanisms, he aims to develop innovative approaches for therapies and preventative medicine.<\/p>\n\n\n\n  <section id=\"block_ca4f1a230aeb784514d73b2b96f8c062\"\n           class=\"section accordion  alignwide \"\n           data-open=\"multiple\">\n    <div class=\"container container--center container--medium\">\n      \n      \n      \n              <div id=\"panel-\"\n             class=\"accordion__category active\" role=\"tabpanel\"\n             aria-labelledby=\"tab-\">\n                    <script type=\"application\/ld+json\">\n            {\n              \"@context\": \"https:\/\/schema.org\",\n              \"@type\": \"FAQPage\",\n              \"mainEntity\": [{\"@type\": \"Question\",\"name\": \"Joint press release by DRFZ and Charit\u00e9\",\"acceptedAnswer\": {\"@type\": \"Answer\",\"text\": \"Targeting chronic inflammation: Prof. Dr. Eicke Latz starts at Charit\u00e9 and DRFZ\nNew Professor of Experimental Rheumatology and Scientific Director of the DRFZ\nThe Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin appointed Prof. Dr. Eicke Latz as Professor of Experimental Rheumatology on 1 May. He simultaneously became the new Scientific Director of the German Rheumatism Research Centre Berlin (DRFZ), a Leibniz Institute. At the interface of both institutes, Prof. Latz will research chronic inflammatory and rheumatic diseases. Through new insights into molecular inflammatory mechanisms, he aims to develop innovative approaches for therapies and preventative medicine.\nProf. Dr. Eicke Latz\u2019s research has focused for many years on how the innate immune system maintains health and under what circumstances it can promote disease. In particular, he investigates the molecular mechanisms that lead to activation or inhibition of the immune system and how these influence the inflammatory reactions in various diseases, such as rheumatic diseases, arteriosclerosis or Alzheimer\u2019s disease. \u201cFor me, however, it is not just about gaining knowledge, but also about being able to successfully translate this into new treatment methods and derive measures for prevention of disease,\u201d explains Prof. Latz. His translational perspective was sharpened by more than a decade of academic research in Boston, a centre of the pharmaceutical and biotech industry. Since his return to Germany, the immunologist has already founded several biotech companies that successfully translate his research findings into new therapeutic and preventive approaches for various inflammatory diseases. Before moving to the Charit\u00e9, he worked at the Institute for Innate Immunity at the University Hospital Bonn, which he founded in 2010.\nAt the Charit\u00e9 and the DRFZ, Prof. Latz would like to use existing synergies to further decipher the molecular basis of chronic inflammatory and rheumatic diseases as well as investigating the influence of environmental factors and lifestyle on such diseases. This research should both contribute to a better understanding of chronic inflammatory diseases and provide a basis for preventive approaches. Prof. Latz is planning on setting up a platform for precision immunodiagnostics, with the aim of such diagnostic procedures to precisely characterise the immunological processes in large groups of patients. Patient-oriented research is also intended to expand knowledge about the molecular mechanisms of inflammatory diseases. The goal: to be able to derive more specific therapies for patients.\n\u201cThe close interlinking of the research groups at the Charit\u00e9 and DRFZ and especially the Department of Rheumatology and Clinical Immunology opens up many opportunities for promising collaboration in both basic research and clinical-translational research. I am looking forward to these synergies and the new tasks,\u201d says Prof. Latz.\nShort biography Prof. Dr. Eicke Latz\nEicke Latz was born in Wiesbaden in 1970. He studied medicine at the Georg-August University in G\u00f6ttingen and the Freien Universit\u00e4t Berlin, following which, he worked as an intensive care physician at the Charit\u00e9. In 2000, he moved to the USA, working as a postdoctoral researcher at Boston University, then at UMass Chan Medical School, where he held his first professorship in innate immunity. In 2010, he returned to Germany and founded the Institute for Innate Immunity at the University Hospital Bonn. Prof. Latz is co-spokesperson of the Cluster of Excellence \u201cImmunoSensation\u00b2\u201d and spokesperson of the Collaborative Research Centre \u201cMetaflammation and Cellular Programming\u201d (SFB 1454). He is also the founder of four biotech companies. Prof. Latz has been a member of the National Academy of Sciences Leopoldina since 2016. In 2018, he received the Gottfried Wilhelm Leibniz Prize for his research on innate immune responses.\"}}]\n            }\n          <\/script>\n\n          <div class=\"accordion__content\">\n                          <div class=\"accordion-item  box box--accordion over launimation slideBottom\">\n                <button class=\"accordion-item__title\"\n                        aria-expanded=\"false\"\n                        aria-controls=\"accordion_69f387568b012_0\"\n                        aria-label=\"Zeige den Inhalt an\">\n                    <span class=\"accordion-item__title-wrapper\">\n                      <span class=\"accordion-item__title-main h5\">Joint press release by DRFZ and Charit\u00e9<\/span>\n                                          <\/span>\n                  <span class=\"icon-wrapper\"><\/span>\n                <\/button>\n\n                <div class=\"accordion-item__content-container\" id=\"accordion_69f387568b012_0\">\n                  <div class=\"accordion-item__content\">\n                    \n                    <div class=\"accordion-item__content-text wysiwyg\">\n                      <h2>Targeting chronic inflammation: Prof. Dr. Eicke Latz starts at Charit\u00e9 and DRFZ<\/h2>\n<p><strong>New Professor of Experimental Rheumatology and Scientific Director of the DRFZ<\/strong><\/p>\n<p><em><strong>The Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin appointed Prof. Dr. Eicke Latz as Professor of Experimental Rheumatology on 1 May. He simultaneously became the new Scientific Director of the German Rheumatism Research Centre Berlin (DRFZ), a Leibniz Institute. At the interface of both institutes, Prof. Latz will research chronic inflammatory and rheumatic diseases. Through new insights into molecular inflammatory mechanisms, he aims to develop innovative approaches for therapies and preventative medicine.<\/strong><\/em><\/p>\n<p>Prof. Dr. Eicke Latz\u2019s research has focused for many years on how the innate immune system maintains health and under what circumstances it can promote disease. In particular, he investigates the molecular mechanisms that lead to activation or inhibition of the immune system and how these influence the inflammatory reactions in various diseases, such as rheumatic diseases, arteriosclerosis or Alzheimer\u2019s disease. \u201cFor me, however, it is not just about gaining knowledge, but also about being able to successfully translate this into new treatment methods and derive measures for prevention of disease,\u201d explains Prof. Latz. His translational perspective was sharpened by more than a decade of academic research in Boston, a centre of the pharmaceutical and biotech industry. Since his return to Germany, the immunologist has already founded several biotech companies that successfully translate his research findings into new therapeutic and preventive approaches for various inflammatory diseases. Before moving to the Charit\u00e9, he worked at the Institute for Innate Immunity at the University Hospital Bonn, which he founded in 2010.<\/p>\n<p>At the Charit\u00e9 and the DRFZ, Prof. Latz would like to use existing synergies to further decipher the molecular basis of chronic inflammatory and rheumatic diseases as well as investigating the influence of environmental factors and lifestyle on such diseases. This research should both contribute to a better understanding of chronic inflammatory diseases and provide a basis for preventive approaches. Prof. Latz is planning on setting up a platform for precision immunodiagnostics, with the aim of such diagnostic procedures to precisely characterise the immunological processes in large groups of patients. Patient-oriented research is also intended to expand knowledge about the molecular mechanisms of inflammatory diseases. The goal: to be able to derive more specific therapies for patients.<\/p>\n<p>\u201cThe close interlinking of the research groups at the Charit\u00e9 and DRFZ and especially the Department of Rheumatology and Clinical Immunology opens up many opportunities for promising collaboration in both basic research and clinical-translational research. I am looking forward to these synergies and the new tasks,\u201d says Prof. Latz.<\/p>\n<p><strong>Short biography Prof. Dr. Eicke Latz<\/strong><\/p>\n<p>Eicke Latz was born in Wiesbaden in 1970. He studied medicine at the Georg-August University in G\u00f6ttingen and the Freien Universit\u00e4t Berlin, following which, he worked as an intensive care physician at the Charit\u00e9. In 2000, he moved to the USA, working as a postdoctoral researcher at Boston University, then at UMass Chan Medical School, where he held his first professorship in innate immunity. In 2010, he returned to Germany and founded the Institute for Innate Immunity at the University Hospital Bonn. Prof. Latz is co-spokesperson of the Cluster of Excellence \u201cImmunoSensation\u00b2\u201d and spokesperson of the Collaborative Research Centre \u201cMetaflammation and Cellular Programming\u201d (SFB 1454). He is also the founder of four biotech companies. Prof. Latz has been a member of the National Academy of Sciences Leopoldina since 2016. In 2018, he received the Gottfried Wilhelm Leibniz Prize for his research on innate immune responses.<\/p>\n\n                                          <\/div>\n                  <\/div>\n                <\/div>\n              <\/div>\n                      <\/div>\n        <\/div>\n          <\/div>\n  <\/section>\n\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/www.charite.de\/service\/pressemitteilung\/artikel\/detail\/chronischen_entzuendungen_auf_der_spur_prof_dr_eicke_latz_startet_an_charite_und_deutschem_rheuma\/\" target=\"_blank\" rel=\"noreferrer noopener\">Link to common press release by DRFZ and Charit\u00e9&nbsp;<\/a><\/div>\n<\/div>\n\n\n\n  <section     class=\"section grid-heads alignwide\">\n    <div class=\"container container--center\">\n      \n              <div class=\"grid-heads__items grid grid--4\">\n          \n<article\n  id=\"post-1685\" class=\"teaser-head launimation slideBottom  post-1685 head type-head status-publish has-post-thumbnail hentry department-directors department-pa-1-cell-and-tissue-rheumatology function-scientific-director programme-area-tax-programme-area-1 working-group-function-group-leader working-group-tax-immunobiology-of-inflammation\">\n  <div class=\"teaser-head__image\">\n          <img decoding=\"async\" loading=\"lazy\" sizes=\"auto, 520px\" src=\"https:\/\/www.drfz.de\/wp-content\/uploads\/2024\/12\/Frame-8635-150x97.png\" data-src=\"https:\/\/www.drfz.de\/wp-content\/uploads\/2024\/12\/Frame-8635-1024x664.png\" data-srcset=\"https:\/\/www.drfz.de\/wp-content\/uploads\/2024\/12\/Frame-8635.png 1920w, https:\/\/www.drfz.de\/wp-content\/uploads\/2024\/12\/Frame-8635.png 1600w, https:\/\/www.drfz.de\/wp-content\/uploads\/2024\/12\/Frame-8635.png 1366w, https:\/\/www.drfz.de\/wp-content\/uploads\/2024\/12\/Frame-8635-1024x664.png 1024w, https:\/\/www.drfz.de\/wp-content\/uploads\/2024\/12\/Frame-8635-768x498.png 768w, https:\/\/www.drfz.de\/wp-content\/uploads\/2024\/12\/Frame-8635-550x357.png 550w\" class=\"image image--landscape\" alt=\"\"  width=\"1024\"  height=\"664\">      <\/div>\n  <div class=\"teaser-head__header\">\n    <!--    -->    <!--      -->    <!--    -->    <h2 class=\"h6 teaser-head__title launimation slideBottom\">Prof. Dr. med. Eicke Latz<\/h2>\n          <div class=\"teaser-head__role\">\n                  <p class=\"text-label function\">Scientific Director<\/p>\n                          <p class=\"text-label programme_area_function programme_area department\">\n            Programme Area 1, Directors          <\/p>\n                          <p class=\"text-label working_group_function working_group\">\n            Group leader: Immunobiology of inflammation          <\/p>\n                      <\/div>\n      <\/div>\n\n      <div class=\"teaser-head__contact\">\n              <p class=\"text-label\"><a href=\"mailto:eicke.latz@drfz.de\"\">eicke.latz@drfz.de<\/a><\/p>\n          <\/div>\n    <a href=\"https:\/\/www.drfz.de\/en\/koepfe\/eicke-latz\/\"\n    aria-describedby=\"post-1685\"\n    title=\"Gehe zum Beitrag\" rel=\"bookmark\"\n    class=\"teaser-head__link button button--small button--arrow button--arrow-link\"><span\n      class=\"visually-hidden\">Prof. Dr. med. Eicke Latz<\/span><\/a>\n<\/article>        <\/div>\n          <\/div>\n  <\/section>\n","protected":false},"excerpt":{"rendered":"<p>Since 1 May 2023, Prof. Dr. med. Eicke Latz is the new Scientific Director of the DRFZ and Professor for Experimental Rheumatology at the Charit\u00e9\u2026<\/p>\n","protected":false},"author":9,"featured_media":11744,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[292,292],"tags":[448,492,493,496,497],"programme-area-tax":[179],"working-group-tax":[250],"class_list":{"0":"post-13762","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","6":"hentry","7":"category-news-en","9":"tag-latz","10":"tag-program-area-1","11":"tag-program-area-2","12":"tag-program-area-3","13":"tag-program-area-4","14":"programme-area-tax-programme-area-1","15":"working-group-tax-immunobiology-of-inflammation"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The new Board of Directors is complete - DRFZ<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.drfz.de\/en\/neuigkeiten\/der-neue-vorstand-ist-komplett\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The new Board of Directors is complete - DRFZ\" \/>\n<meta property=\"og:description\" content=\"Since 1 May 2023, Prof. Dr. med. Eicke Latz is the new Scientific Director of the DRFZ and Professor for Experimental Rheumatology at the Charit\u00e9\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.drfz.de\/en\/neuigkeiten\/der-neue-vorstand-ist-komplett\/\" \/>\n<meta property=\"og:site_name\" content=\"DRFZ\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/drfz.de\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-02T10:21:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-11T13:46:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.drfz.de\/wp-content\/uploads\/2025\/02\/2023_05_02_Der-neue-Vorstand-ist-komplett-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Viet Hoang\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DRFZ_Berlin\" \/>\n<meta name=\"twitter:site\" content=\"@DRFZ_Berlin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Viet Hoang\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/der-neue-vorstand-ist-komplett\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/der-neue-vorstand-ist-komplett\\\/\"},\"author\":{\"name\":\"Viet Hoang\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#\\\/schema\\\/person\\\/bfb3defd73223982109dc1eafd951bd3\"},\"headline\":\"The new Board of Directors is complete\",\"datePublished\":\"2023-05-02T10:21:00+00:00\",\"dateModified\":\"2025-03-11T13:46:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/der-neue-vorstand-ist-komplett\\\/\"},\"wordCount\":145,\"publisher\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/der-neue-vorstand-ist-komplett\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/2023_05_02_Der-neue-Vorstand-ist-komplett-1.jpg\",\"keywords\":[\"Latz\",\"Program area 1\",\"Program area 2\",\"Program area 3\",\"Program area 4\"],\"articleSection\":[\"News\",\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/der-neue-vorstand-ist-komplett\\\/\",\"url\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/der-neue-vorstand-ist-komplett\\\/\",\"name\":\"The new Board of Directors is complete - DRFZ\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/der-neue-vorstand-ist-komplett\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/der-neue-vorstand-ist-komplett\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/2023_05_02_Der-neue-Vorstand-ist-komplett-1.jpg\",\"datePublished\":\"2023-05-02T10:21:00+00:00\",\"dateModified\":\"2025-03-11T13:46:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/der-neue-vorstand-ist-komplett\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/der-neue-vorstand-ist-komplett\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/der-neue-vorstand-ist-komplett\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/2023_05_02_Der-neue-Vorstand-ist-komplett-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/2023_05_02_Der-neue-Vorstand-ist-komplett-1.jpg\",\"width\":800,\"height\":450,\"caption\":\"Uta Bielfeldt and Eicke Latz \u00a9 Jacqueline Hirscher\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/der-neue-vorstand-ist-komplett\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"The new Board of Directors is complete\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/\",\"name\":\"DRFZ\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#organization\",\"name\":\"Deutsches Rheuma-Forschungszentrum\",\"url\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/drfz-footer-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/drfz-footer-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Deutsches Rheuma-Forschungszentrum\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/drfz.de\\\/\",\"https:\\\/\\\/x.com\\\/DRFZ_Berlin\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/deutsches-rheuma-forschungszentrum-berlin\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCf8nDuqpkWwcmCWmfSTkE3w\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#\\\/schema\\\/person\\\/bfb3defd73223982109dc1eafd951bd3\",\"name\":\"Viet Hoang\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f8b96e1b0aba912be35271142abfbb8039fdd9593cd9d332398b53a8f5b7156e?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f8b96e1b0aba912be35271142abfbb8039fdd9593cd9d332398b53a8f5b7156e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f8b96e1b0aba912be35271142abfbb8039fdd9593cd9d332398b53a8f5b7156e?s=96&d=mm&r=g\",\"caption\":\"Viet Hoang\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The new Board of Directors is complete - DRFZ","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.drfz.de\/en\/neuigkeiten\/der-neue-vorstand-ist-komplett\/","og_locale":"en_US","og_type":"article","og_title":"The new Board of Directors is complete - DRFZ","og_description":"Since 1 May 2023, Prof. Dr. med. Eicke Latz is the new Scientific Director of the DRFZ and Professor for Experimental Rheumatology at the Charit\u00e9\u2026","og_url":"https:\/\/www.drfz.de\/en\/neuigkeiten\/der-neue-vorstand-ist-komplett\/","og_site_name":"DRFZ","article_publisher":"https:\/\/www.facebook.com\/drfz.de\/","article_published_time":"2023-05-02T10:21:00+00:00","article_modified_time":"2025-03-11T13:46:23+00:00","og_image":[{"width":800,"height":450,"url":"https:\/\/www.drfz.de\/wp-content\/uploads\/2025\/02\/2023_05_02_Der-neue-Vorstand-ist-komplett-1.jpg","type":"image\/jpeg"}],"author":"Viet Hoang","twitter_card":"summary_large_image","twitter_creator":"@DRFZ_Berlin","twitter_site":"@DRFZ_Berlin","twitter_misc":{"Written by":"Viet Hoang","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/der-neue-vorstand-ist-komplett\/#article","isPartOf":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/der-neue-vorstand-ist-komplett\/"},"author":{"name":"Viet Hoang","@id":"https:\/\/www.drfz.de\/en\/#\/schema\/person\/bfb3defd73223982109dc1eafd951bd3"},"headline":"The new Board of Directors is complete","datePublished":"2023-05-02T10:21:00+00:00","dateModified":"2025-03-11T13:46:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/der-neue-vorstand-ist-komplett\/"},"wordCount":145,"publisher":{"@id":"https:\/\/www.drfz.de\/en\/#organization"},"image":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/der-neue-vorstand-ist-komplett\/#primaryimage"},"thumbnailUrl":"https:\/\/www.drfz.de\/wp-content\/uploads\/2025\/02\/2023_05_02_Der-neue-Vorstand-ist-komplett-1.jpg","keywords":["Latz","Program area 1","Program area 2","Program area 3","Program area 4"],"articleSection":["News","News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/der-neue-vorstand-ist-komplett\/","url":"https:\/\/www.drfz.de\/en\/neuigkeiten\/der-neue-vorstand-ist-komplett\/","name":"The new Board of Directors is complete - DRFZ","isPartOf":{"@id":"https:\/\/www.drfz.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/der-neue-vorstand-ist-komplett\/#primaryimage"},"image":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/der-neue-vorstand-ist-komplett\/#primaryimage"},"thumbnailUrl":"https:\/\/www.drfz.de\/wp-content\/uploads\/2025\/02\/2023_05_02_Der-neue-Vorstand-ist-komplett-1.jpg","datePublished":"2023-05-02T10:21:00+00:00","dateModified":"2025-03-11T13:46:23+00:00","breadcrumb":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/der-neue-vorstand-ist-komplett\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.drfz.de\/en\/neuigkeiten\/der-neue-vorstand-ist-komplett\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/der-neue-vorstand-ist-komplett\/#primaryimage","url":"https:\/\/www.drfz.de\/wp-content\/uploads\/2025\/02\/2023_05_02_Der-neue-Vorstand-ist-komplett-1.jpg","contentUrl":"https:\/\/www.drfz.de\/wp-content\/uploads\/2025\/02\/2023_05_02_Der-neue-Vorstand-ist-komplett-1.jpg","width":800,"height":450,"caption":"Uta Bielfeldt and Eicke Latz \u00a9 Jacqueline Hirscher"},{"@type":"BreadcrumbList","@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/der-neue-vorstand-ist-komplett\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.drfz.de\/en\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.drfz.de\/en\/news\/"},{"@type":"ListItem","position":3,"name":"The new Board of Directors is complete"}]},{"@type":"WebSite","@id":"https:\/\/www.drfz.de\/en\/#website","url":"https:\/\/www.drfz.de\/en\/","name":"DRFZ","description":"","publisher":{"@id":"https:\/\/www.drfz.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.drfz.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.drfz.de\/en\/#organization","name":"Deutsches Rheuma-Forschungszentrum","url":"https:\/\/www.drfz.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.drfz.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.drfz.de\/wp-content\/uploads\/2024\/10\/drfz-footer-logo.svg","contentUrl":"https:\/\/www.drfz.de\/wp-content\/uploads\/2024\/10\/drfz-footer-logo.svg","width":1,"height":1,"caption":"Deutsches Rheuma-Forschungszentrum"},"image":{"@id":"https:\/\/www.drfz.de\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/drfz.de\/","https:\/\/x.com\/DRFZ_Berlin","https:\/\/www.linkedin.com\/company\/deutsches-rheuma-forschungszentrum-berlin","https:\/\/www.youtube.com\/channel\/UCf8nDuqpkWwcmCWmfSTkE3w"]},{"@type":"Person","@id":"https:\/\/www.drfz.de\/en\/#\/schema\/person\/bfb3defd73223982109dc1eafd951bd3","name":"Viet Hoang","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f8b96e1b0aba912be35271142abfbb8039fdd9593cd9d332398b53a8f5b7156e?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f8b96e1b0aba912be35271142abfbb8039fdd9593cd9d332398b53a8f5b7156e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f8b96e1b0aba912be35271142abfbb8039fdd9593cd9d332398b53a8f5b7156e?s=96&d=mm&r=g","caption":"Viet Hoang"}}]}},"_links":{"self":[{"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/posts\/13762","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/comments?post=13762"}],"version-history":[{"count":4,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/posts\/13762\/revisions"}],"predecessor-version":[{"id":13768,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/posts\/13762\/revisions\/13768"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/media\/11744"}],"wp:attachment":[{"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/media?parent=13762"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/categories?post=13762"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/tags?post=13762"},{"taxonomy":"programme-area-tax","embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/programme-area-tax?post=13762"},{"taxonomy":"working-group-tax","embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/working-group-tax?post=13762"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}